Agf Investments LLC Allogene Therapeutics, Inc. Transaction History

Agf Investments LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 01, 2022	SELL	$13.13 - $24.52 $341,537 - $637,814	-26,012 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$21.01 - $27.64 $32,733 - $43,063	1,558 Added 6.37%	26,012 $669,000
Q2 2021 Aug 12, 2021	BUY	$23.49 - $35.8 $574,424 - $875,453	24,454 New	24,454 $638,000
Q3 2020 Nov 12, 2020	SELL	$32.38 - $44.96 $15,250 - $21,176	-471 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$18.39 - $54.04 $8,661 - $25,452	471 New	471 $20,000

162

134M

59.4K

113K

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $326M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

Get notified when there are updates to the investment portfolio of Agf Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Agf Investments LLC with notifications on news.